Care

Truepill inked a deal with Health Transformation Alliance in order to offer its new services to the latter's members. 

The collaboration will augment AI with remote care automation to improve patient care.

The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.

The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.

Value-based care implies radical, even disruptive changes to the current practice, say Paulus Torkki, associate professor of healthcare operations management at University of Helsinki and Marianna Imenokhoeva, founder of LinktoMedicine and HIMSS Future50 Leader. 

Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.

Lina Chan, CEO and founder of Parla reviews femtech's roles in tackling taboo subjects in women's health and outlines the importance of involving women affected in the design process.

The system delivers its results to a companion app in about 20 minutes, according to the agency.

Deprexis, an app used to help mental health, is the 11th app to be approved for medical prescription and reimbursement in Germany so far via DiGA, and MobiHealthNews learns more about the process from Julia Hagen, Health Innovation Hub.

Also: Oscar Health IPO dips below expectations; DrChrono's new "all-in-one telehealth app experience."